Condroin Forte series MultiVita

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.051240.11.11
Date of registration and renewal:17.11.2011
Dosage form: & nbspTableti with a mass of 948.0 mg
Classification "Composition" & nbsp Dietary supplements - proteins, amino acids and their derivatives Supplements - vitamins, vitamin-like substances and coenzymes BAD - products of plant, animal or mineral origin
Classification "Clinical" & nbsp BAD-source of monovitamins and vitamin-like substances
Composition: & nbspIngredients: glucosamine sulfate, dicalcium chloride, chondroitin sulfate, sodium Auxiliary components: corn starch, lactose monohydrate, calcium hydrogen phosphate dihydrate (E341), shellac (E904), gum arabic (E414), MCC (E460), long chain partial glycerides, magnesium stearate (E470), croscarmellose (E468), silicon dioxide (E551), talc (E553)
Scope: & nbspDFor sale to the population through the pharmacy network and specialized stores, the trade network departments as a biologically active food additive - the source of glucosamine sulfate, chondroitin sulfate (APPENDIX)
Suggested Usage: & nbspAdults take 1 tablet a day with meals. Duration of admission is 40 days. If necessary, the reception can be repeated.
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry place, protected from light, not accessible to children at a temperature not exceeding + 25 ° С.
Research protocols:EThe Federal Agency for the Federal Treasury and Federal Service for Consumer Protection of the Russian Federation No. 10-2FTS / 1107 dated March 10, 2010
Recipient:HEMOFARM JOINT STOCK COMPANY PHARMACEUTICAL AND CHEMICAL INDUSTRYHEMOFARM JOINT STOCK COMPANY PHARMACEUTICAL AND CHEMICAL INDUSTRY
Information update date: & nbsp14.07.2016
Instructions
Up